The psychometric properties of the St George's Respiratory Questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: a literature review (Q26992007)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The psychometric properties of the St George's Respiratory Questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: a literature review	scientific article

Statements

scholarly article

1 reference

5 references

19 June 2019

23 July 2019

19 September 2019

23 November 2020

6 April 2021

The psychometric properties of the St George's Respiratory Questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: a literature review (English)

1 reference

0 references

0 references

idiopathic pulmonary fibrosis

3 references

19 June 2019

23 July 2019

19 September 2019

quality of life

1 reference

23 July 2019

biomedical investigative technique

1 reference

19 September 2019

pulmonary fibrosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

health indicator

1 reference

23 November 2020

patient outcome assessment

1 reference

6 April 2021

Psychometric Property

1 reference

based on heuristic

inferred from title

author name string

Jeffrey J Swigris

1

1 reference

Dirk Esser

2

1 reference

Craig S Conoscenti

3

1 reference

Kevin K Brown

4

1 reference

language of work or name

1 reference

publication date

20 August 2014

6 references

19 June 2019

23 July 2019

19 September 2019

23 November 2020

6 April 2021

Health and Quality of Life Outcomes

6 references

19 June 2019

23 July 2019

19 September 2019

23 November 2020

6 April 2021

12

1 reference

124

1 reference

copyright license

Creative Commons Attribution

5 references

19 June 2019

23 July 2019

19 September 2019

23 November 2020

6 April 2021

copyright status

0 references

on focus list of Wikimedia project

0 references

Long-acting beta2-agonists for chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148554

21 March 2017

Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148554

21 March 2017

Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148554

21 March 2017

Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148554

21 March 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148554

7 April 2017

A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148554

21 March 2017

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148554

21 March 2017

Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148554

21 March 2017

Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148554

7 April 2017

Minimal clinically important differences in pharmacological trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148554

28 September 2017

A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148554

28 September 2017

Health-related quality of life in idiopathic pulmonary fibrosis: where are we now?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148554

28 September 2017

Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148554

28 September 2017

Validation of the Cough Quality-of-Life Questionnaire in patients with idiopathic pulmonary fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148554

28 September 2017

Patient-reported outcomes in idiopathic pulmonary fibrosis research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148554

28 September 2017

The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148554

28 September 2017

Relationship between lung function impairment and health-related quality of life in COPD and interstitial lung disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148554

28 September 2017

Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148554

28 September 2017

Health-related quality of life and 6 min walk distance in patients with idiopathic pulmonary fibrosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148554

28 September 2017

An alternative therapy for idiopathic pulmonary fibrosis by doxycycline through matrix metalloproteinase inhibition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148554

28 September 2017

Comparative efficacy of indacaterol 150 μg and 300 μg versus fixed-dose combinations of formoterol budesonide or salmeterol fluticasone for the treatment of chronic obstructive pulmonary disease--a network meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148554

28 September 2017

Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148554

28 September 2017

Development and validity testing of an IPF-specific version of the St George's Respiratory Questionnaire

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148554

28 September 2017

Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148554

28 September 2017

A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148554

28 September 2017

The SF-36 and SGRQ: validity and first look at minimum important differences in IPF.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148554

28 September 2017

Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148554

28 September 2017

Health-related quality of life among patients with idiopathic pulmonary fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148554

28 September 2017

Interpreting thresholds for a clinically significant change in health status in asthma and COPD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148554

28 September 2017

Assessment of health-related quality of life in patients with interstitial lung disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148554

28 September 2017

Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference

1 reference

https://api.crossref.org/works/10.1186/S12955-014-0124-1

21 January 2018

Thalidomide for the treatment of cough in idiopathic pulmonary fibrosis: a randomized trial

1 reference

https://api.crossref.org/works/10.1186/S12955-014-0124-1

21 January 2018

BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1186/S12955-014-0124-1

21 January 2018

Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor?

1 reference

https://api.crossref.org/works/10.1186/S12955-014-0124-1

21 January 2018

Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis.

1 reference

https://api.crossref.org/works/10.1186/S12955-014-0124-1

21 January 2018

Cross-sectional and longitudinal construct validity of the Saint George's Respiratory Questionnaire in patients with IPF.

1 reference

https://api.crossref.org/works/10.1186/S12955-014-0124-1

21 January 2018

A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1186/S12955-014-0124-1

21 January 2018

Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1186/S12955-014-0124-1

21 January 2018

Home-based pulmonary rehabilitation in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1186/S12955-014-0124-1

21 January 2018

Evaluation of health-related quality-of-life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests

1 reference

https://api.crossref.org/works/10.1186/S12955-014-0124-1

21 January 2018

Comparison of two questionnaires which measure the health-related quality of life of idiopathic pulmonary fibrosis patients.

1 reference

https://api.crossref.org/works/10.1186/S12955-014-0124-1

21 January 2018

The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire

1 reference

https://api.crossref.org/works/10.1186/S12955-014-0124-1

21 January 2018

St. George's Respiratory Questionnaire: MCID

1 reference

https://pubmed.ncbi.nlm.nih.gov/25138056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25138056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes

1 reference

https://pubmed.ncbi.nlm.nih.gov/25138056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The St George's Respiratory Questionnaire

1 reference

https://pubmed.ncbi.nlm.nih.gov/25138056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of pulmonary rehabilitation in restrictive lung disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25138056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/S12955-014-0124-1

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26992007&oldid=2177297390"